{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:19:59Z","timestamp":1790698799388,"version":"4.1.0"},"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002447","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T17:23:26Z","timestamp":1385054606000},"page":"e2447","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":213,"title":["A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis"],"prefix":"10.1371","volume":"7","author":[{"given":"Alison","family":"Krentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter U.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"ref1","first-page":"377","article-title":"Global programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"PJ Hotez","year":"2007","journal-title":"New Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected diseases","volume":"373","author":"PJ Hotez","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1366","DOI":"10.1371\/journal.pntd.0001366","article-title":"The emerging story of disability associated with lymphatic filariasis: a critical review","volume":"5","author":"LM Zeldenryk","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pntd.0000128","article-title":"Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis","volume":"1","author":"M Perera","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","unstructured":"(1997) Elimination of lymphatic filariasis as a public health problem. Document WHA50\/1997\/REC\/1."},{"key":"ref7","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"EA Ottesen","year":"1997","journal-title":"Bull World Health Organ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"The global programme to eliminate lymphatic filarisis","volume":"5","author":"EA Ottesen","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref9","first-page":"346","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2011","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0035-9203(89)90343-X","article-title":"Towards a filariasis-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia","volume":"83","author":"F Partono","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"B Babu","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ref12","first-page":"313","article-title":"Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study","volume":"45","author":"C Lahariya","year":"2008","journal-title":"J Vector Borne Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1179\/136485906X105598","article-title":"A campaign of \u2018communication for behavioural impact\u2019 to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage","volume":"100","author":"KD Ramaiah","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref14","first-page":"61","article-title":"Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India","volume":"47","author":"BG Ranganath","year":"2010","journal-title":"J Vector Borne Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4269\/ajtmh.2005.73.753","article-title":"Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach","volume":"73","author":"M Fraser","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/004947550303300208","article-title":"Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India","volume":"33","author":"BV Babu","year":"2003","journal-title":"Trop Doct"},{"key":"ref17","first-page":"51","article-title":"Study on the factors affecting the MDA programme in Kerala state","volume":"39","author":"MK Showkath Ali","year":"2007","journal-title":"J Commun Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2883-6-11","article-title":"Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka","volume":"6","author":"MV Weerasooriya","year":"2007","journal-title":"Filaria J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-3156.2000.00659.x","article-title":"A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects","volume":"5","author":"KD Ramaiah","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-3156.2003.01033.x","article-title":"Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis","volume":"8","author":"IP Sunish","year":"2003","journal-title":"Trop Med Int Health"},{"key":"ref21","first-page":"327","article-title":"The integration of neglected diseases: three years of experience in Togo","volume":"81","author":"G Anthony","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","article-title":"Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance","volume":"102","author":"BV Babu","year":"2008","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e640","DOI":"10.1371\/journal.pntd.0000640","article-title":"A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti","volume":"4","author":"A Boyd","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-3156.2009.02443.x","article-title":"Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008","volume":"15","author":"PT Cantey","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1371\/journal.pntd.0000728","article-title":"Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs","volume":"4","author":"PT Cantey","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2006.09.002","article-title":"Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka","volume":"101","author":"S Gunawardena","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-3156.2006.01626.x","article-title":"Participation in three consecutive mass drug administrations in Leogane, Haiti","volume":"11","author":"E Mathieu","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1179\/000349804X3135","article-title":"Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti","volume":"98","author":"E Mathieu","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1371\/journal.pntd.0001286","article-title":"The impact of a filariasis control program on Lihir Island, Papua New Guinea","volume":"5","author":"O Mitj\u00e0","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref30","first-page":"333","article-title":"Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State","volume":"38","author":"K Regu","year":"2006","journal-title":"J Commun Dis"},{"key":"ref31","first-page":"101","article-title":"A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India","volume":"48","author":"P Ray Karmakar","year":"2011","journal-title":"J Vector Borne Dis"},{"key":"ref32","first-page":"14","article-title":"Prospects of elimination of lymphatic filariasis in India","volume":"32","author":"PK Das","year":"2002","journal-title":"ICMR Bulletin"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-3305-1-14","article-title":"Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines","volume":"1","author":"ML Amarillo","year":"2008","journal-title":"Parasit Vectors"},{"key":"ref34","first-page":"69","article-title":"Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programmes for elimination of lymphatic filariasis","volume":"13","author":"N Wamae","year":"2006","journal-title":"Afr J Health Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pt.2006.05.010","article-title":"Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme","volume":"22","author":"KA Mohammed","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1046\/j.1365-3156.2001.00813.x","article-title":"Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India","volume":"6","author":"KD Ramaiah","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.inhe.2010.12.001","article-title":"Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India","volume":"3","author":"ZT Nujum","year":"2011","journal-title":"International Health (RSTMH)"},{"key":"ref38","first-page":"113","article-title":"Coverage and compliance to diethylcarbamazine in relation to Filaria Prevention Assistants in rural Puducherry, India","volume":"47","author":"T Mahalakshmy","year":"2010","journal-title":"J Vector Borne Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2883-6-7","article-title":"Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience","volume":"6","author":"B Nandha","year":"2007","journal-title":"Filaria J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00034983.2001.11813617","article-title":"Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana","volume":"95","author":"M Gyapong","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.actatropica.2010.08.021","article-title":"Improving community participation to eliminate lymphatic filariasis in American Samoa","volume":"120S","author":"JD King","year":"2011","journal-title":"Acta Trop"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1179\/000349809X12459740922255","article-title":"Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala","volume":"103","author":"S Aswathy","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/10158782.2012.11441487","article-title":"Factors associated with the motivation of community drug distributors in the Lymphatic Filariasis Elimination Programme in Kenya","volume":"27","author":"DW Njomo","year":"2012","journal-title":"South Afr J Epidemiol Infect"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1995-7645(10)60033-8","article-title":"A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa, India","volume":"3","author":"BV Babu","year":"2010","journal-title":"Asian Pacific J Trop Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1179\/000349804225021433","article-title":"The programme to eliminate lymphatic filariasis in Orissa, India: the attitudes of some programme partners","volume":"98","author":"BV Babu","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1010539508327032","article-title":"Clinician's attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India","volume":"21","author":"AS Kerketta","year":"2009","journal-title":"Asia Pac J Public Health"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4269\/ajtmh.2007.77.1069","article-title":"The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt","volume":"77","author":"M El-Setouhy","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref48","first-page":"67","article-title":"Socio-economic and behavioural factors that influence compliance with mass treatment in the national programme for elimination of lymphatic filariasis in Kenya","volume":"83","author":"D Njomo","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1179\/000349802125001726","article-title":"The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia","volume":"96","author":"R Rajendran","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref50","unstructured":"Sapak P, Melrose W, Durrheim D, Pawa F, Wynd S, et al. (2004) Evaluation of the lymphatic filariasis control program Samarai Murua District, Papua New Guinea. Warwick, Queensland: Warwick Educational Publishing."},{"key":"ref51","first-page":"293","article-title":"Increased adherence to mass drug administration for lymphatic filariasis - Orissa State, India, 2009","volume":"91","author":"PT Cantey","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1756-3305-3-120","article-title":"High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone","volume":"3","author":"MH Hodges","year":"2012","journal-title":"Parasit Vectors"},{"key":"ref53","first-page":"149","article-title":"Independent assessment of Mass Drug Administration in filariasis affected Surat city","volume":"38","author":"KG Vaishnav","year":"2006","journal-title":"J Commun Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/1755-6783.95962","article-title":"Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results","volume":"5","author":"DW Njomo","year":"2012","journal-title":"Ann Trop Med PH"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/136485905X29701","article-title":"Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis","volume":"99","author":"KD Ramaiah","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1179\/000349809X12502035776630","article-title":"Lymphatic filariasis: patients and the global elimination programme","volume":"103","author":"CD Mackenzie","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1365-3156.2006.01720.x","article-title":"Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia","volume":"11","author":"A Krentel","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref58","first-page":"42","article-title":"Social mobilization and compliance with mass treatment for lymphatic filariasis elimination in Kenya","volume":"20","author":"DW Njomo","year":"2012","journal-title":"Afr J Health Sci"},{"key":"ref59","first-page":"237","article-title":"A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India","volume":"46","author":"A Kumar","year":"2009","journal-title":"J Vector Borne Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4066\/AMJ.2010.479","article-title":"Mass drug administration to eliminate lymphatic filariasis in Southern India","volume":"3","author":"S Pattanshetty","year":"2010","journal-title":"AMJ"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4038\/cmj.v46i4.6431","article-title":"Compliance with the mass chemotherapy program for lymphatic filariasis","volume":"46","author":"KT Kasturiratne","year":"2001","journal-title":"Ceylon Med J"},{"key":"ref62","first-page":"384","article-title":"Causal chain mapping: a novel method to analyse treatment compliance decisions relating to lymphatic filariasis elimination in Alor, Indonesia","author":"A Krentel","year":"2011","journal-title":"Health Policy Plan"},{"key":"ref63","first-page":"37","article-title":"Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State","volume":"40","author":"AM Showkath","year":"2008","journal-title":"J Commun Diseases"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pt.2005.05.015","article-title":"Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis","volume":"21","author":"KD Ramaiah","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/004947550303300120","article-title":"Healthcare workers' knowledge of lymphatic filariasis and its control in an endemic area of Eastern India: implications on control programme","volume":"33","author":"BV Babu","year":"2003","journal-title":"Trop Doct"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-3305-3-70","article-title":"Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia","volume":"3","author":"N Bhullar","year":"2010","journal-title":"Parasit Vectors"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea","volume":"347","author":"MJ Bockarie","year":"2002","journal-title":"New Engl J Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/136485905X29666","article-title":"Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India","volume":"99","author":"P Vanamail","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2004.71.466","article-title":"Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs","volume":"71","author":"MB de Rochars","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-3156.2002.00894.x","article-title":"Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India","volume":"7","author":"TR Mani","year":"2002","journal-title":"Trop Med Int Health"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4269\/ajtmh.2008.78.283","article-title":"Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti","volume":"78","author":"JT Talbot","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1179\/136485906X118521","article-title":"Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis","volume":"100","author":"BV Babu","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pntd.0000344","article-title":"The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea","volume":"2","author":"GJ Weil","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-6-1","article-title":"Socio-cultural insights and lymphatic filariasis control - lessons from the Pacific","volume":"6","author":"S Wynd","year":"2007","journal-title":"Filaria J"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/136485907X176364","article-title":"Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka","volume":"101","author":"GS Gunawardena","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1017\/S0031182008000437","article-title":"LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages","volume":"135","author":"WA Stolk","year":"2008","journal-title":"Parasitology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cis486","article-title":"Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial","volume":"55","author":"S Mand","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2471\/BLT.06.031047","article-title":"Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature","volume":"85","author":"S Wynd","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4269\/ajtmh.2006.75.928","article-title":"Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti","volume":"75","author":"N Hochberg","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"PJ Hotez","year":"2009","journal-title":"Lancet"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2883-6-4","article-title":"Physical disability and psychosocial impact due to chronic filarial lymphoedema in Sri Lanka","volume":"6","author":"RS Wijesinghe","year":"2007","journal-title":"Filaria J"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pt.2012.03.001","article-title":"Neglected tropical diseases and mental health: a perspective on comorbidity","volume":"28","author":"E Litt","year":"2012","journal-title":"Trend Parasitol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1756-3305-4-234","article-title":"Neglected tropical diseases and the millennium development goals-why the \u201cother diseases\u201d matter: reality versus rhetoric","volume":"4","author":"DH Molyneux","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref84","unstructured":"WHO (2011) Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva, Switzerland."},{"key":"ref85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14787210.7.1.37","article-title":"Prospects for the control of neglected tropical diseases by mass drug administration","volume":"7","author":"HL Smits","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref86"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","article-title":"Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs","volume":"79","author":"D Kyelem","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pt.2006.08.011","article-title":"Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions","volume":"22","author":"E Michael","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"e1984","DOI":"10.1371\/journal.pntd.0001984","article-title":"Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis","volume":"7","author":"WA Stolk","year":"2013","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T19:09:03Z","timestamp":1564859343000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002447"}},"subtitle":[],"editor":[{"given":"David G.","family":"Addiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":89,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002447","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}